STAT

FEBRUARY 29, 2024

At a meeting Thursday of the Advisory Committee on Immunization Practices, vaccine safety experts from the two agencies presented data that showed what appears to be an elevated rate of GBS, as the condition is called, among people who got the Pfizer vaccine, although there were also cases detected among people who got the GSK product.

Vaccines 360

Vaccines Immunity Immunization 360

STAT

APRIL 10, 2024

But as researchers from different companies and academic institutions presented promising early data at the American Association for Cancer Research annual meeting in San Diego this week, experts said there’s a collective feeling of turning a corner. SAN DIEGO — Cancer vaccines have traveled a potholed road over the last decade.

Vaccines 364

Vaccines Immunity Immunization Drug Development 364

STAT

DECEMBER 10, 2022

NEW ORLEANS — Researchers had hoped in recent years that a protein called GPRC5D might offer a new way to get the immune system to hunt down and destroy multiple myeloma cells. Now, the results of a Phase 2 study on a bispecific antibody targeting this protein offers confirmation.

Immunity 322

Immunity Immunization 322

STAT

FEBRUARY 29, 2024

The vaccine effectiveness estimates, which showed unusually robust protection of children against influenza B viruses but more modest protection of people aged 65 and older against influenza A viruses, were presented Wednesday at a meeting of the CDC’s expert vaccine panel, the Advisory Committee on Immunization Practices.

Vaccines 303

Vaccines Immunity Immunization 303

pharmaphorum

JULY 26, 2021

While there are plenty of tests already available that can give a yes/no reading of whether antibodies are present, the Chembio test measures the level of antibodies as well, so can tell whether a patient is likely to be protected against the coronavirus. The post Rapid COVID immune status test launched in UK, Ireland appeared first on.

Immunity 137

Immunity Immunization Vaccines 137

STAT

FEBRUARY 22, 2023

The data were presented Wednesday to the Advisory Committee on Immunization Policy, which advises the Centers for Disease Control and Prevention. Read the rest…

Immunity 246

Immunity Immunization Hospitals Vaccines 246

European Pharmaceutical Review

MARCH 6, 2023

Investigators assessed whether administering a temperature-stable vaccine containing both ID93 and GLA-SE in a single vial would be as effective at inducing an immune response as a regimen in which non-thermostable ID93 and liquid GLA-SE are held in two vials and combined prior to injection. However, Sagawa et al.

Immunity 103

Immunity Immunization Vaccines Communication 103

European Pharmaceutical Review

OCTOBER 20, 2022

Recognising the potential of CAR T cells to act as highly targeted therapeutics, several biotechnology companies – including Sangamo Therapeutics – have established development pipelines of CAR T regulatory cells (Tregs) that aim to tackle immune?mediated What are Tregs and how are they applicable to immune-mediated disease?

Immunity 140

Immunity Immunization Drug Development 140

STAT

OCTOBER 8, 2024

So join us as we hoist the ever-present cup of stimulation — our choice today is coconut rum — and attack the fast-growing to-do list. Lots of sunshine and clear blue skies are once again enveloping the Pharmalot campus, where the official mascots are bounding about the grounds in search of creatures to annoy. ” A U.S.

Compounding 265

Compounding Compounding Pharmacies Vaccines Immunity 265

European Pharmaceutical Review

JUNE 13, 2023

Instead, the study tested for an immune response at levels that are thought to protect against the disease if infected with the virus. The post Chikungunya vaccine demonstrates 99 percent immune response appeared first on European Pharmaceutical Review. Results from the Phase III clinical trial was published in The Lancet.

Immunity 105

Immunity Immunization Vaccines 105

European Pharmaceutical Review

AUGUST 25, 2022

This strategy has failed to gain a foothold in the past as the patient’s immune system interferes, destroying the unprotected oncolytic viruses. 7 Studies also sought to modify oncolytic viruses with additional genes that more efficiently recruit the patient’s immune system to target tumour cells. suppressing activity.

Immunity 111

Immunity Immunization Chemotherapy Packaging 111

Express Pharma

JUNE 20, 2023

The vaccine efforts of the COVID-19 pandemic highlighted our knowledge about gaps in the immune system. Reductionist systems, such as genetically identical inbred mice, have long been the choice for immunology research, which focuses on studying the cells, tissues, and organs that make up the immune system.

Immunity 105

Immunity Immunization Vaccines Hospitals 105

LifeProNow

APRIL 9, 2025

These results were first presented at theECTRIMSconference on September 20, 2024 in Copenhagen, Denmark and further analyses were also presented today during the Clinical Trials Plenary Session at the 2025 Annual Meeting for the American Academy of Neurology (AAN) in San Diego, California. 0.88; p=0.003).

Immunity 100

Immunity Immunization 100

World Pharma News

JANUARY 29, 2024

A new technology to increase visibility of cancer cells to the immune system using CRISPR has been developed, and could lead to a new way to treat cancer. Major histocompatibility complex (MHC) class I molecules are an immune complex present on the surface of all cells in humans.

Immunity 84

Immunity Immunization 84

Pharmafile

APRIL 1, 2025

Secarna Pharmaceuticals will present new preclinical data with its lead programme SECN-15 at the American Association for Cancer Research (AACR) taking place 25 to 30 April 2025 in Chicago, Illinois, US. Data will showcase SECN-15s potential to significantly improve the efficacy of immune checkpoint inhibitors (ICIs).

Immunity 59

Immunity Immunization 59

pharmaphorum

NOVEMBER 4, 2021

While still preliminary, the experience with the two patients back up Talaris’ hope that giving a one-shot dose of FCR001 the day after an organ transplant could stimulate immune tolerance in the recipient, and avoid the side effects of current drug treatments such as infections, heart disease, and some forms of cancer.

Immunity 98

Immunity Immunization 98

World Pharma News

OCTOBER 9, 2023

NYSE: PFE) will present data across its infectious disease portfolio at the upcoming IDWeek 2023 held in Boston from October 11-15, 2023. Pfizer Inc. Data from 45 abstracts will highlight the advances Pfizer is making in helping prevent and treat certain infectious diseases, particularly respiratory illnesses.

Vaccines 98

Vaccines Immunity Immunization 98

Pharma Times

APRIL 17, 2023

Efti’s targeting activation of antigen-presenting cells delivers an adaptive immunity to fight cancer

Immunization 130

Immunization Immunity 130

ALiEM - Pharm Pearls

OCTOBER 11, 2024

A 76-year-old female presented with a lingering cough and an oral lesion to the left lower cheek. On the day of presentation, she developed a painful, intermittently bleeding “blood blister” to the left lower cheek that had increased in size, as well as new red spots on her arms and legs. Physical Exam Vitals : 98.3°F; Plt 6, WBC 10.3

Immunity 152

Immunity Immunization 152

ALiEM - Pharm Pearls

MARCH 29, 2023

If LP is traumatic or pleocytosis is present, administer antibiotics and admit. Example: A 48-day-old infant presents with a fever of 100.6F, CRP of 22 mg/L, and otherwise normal procalcitonin, ANC, and UA. This requires a documented positive viral swab and not just a presentation consistent with a viral syndrome.

Hospitals 360

Hospitals Documentation Inpatient Immunity 360

ALiEM - Pharm Pearls

DECEMBER 18, 2023

A 19-year-old female with a past medical history of epilepsy presented to the emergency department for evaluation of rash and fever. Two days prior to presentation she began to experience fevers with a Tmax of 103°F. Diagnosis can be extremely challenging due to the variability in clinical presentation. Int J Mol Sci.

Immunity 177

Immunity Immunization 177

ALiEM - Pharm Pearls

OCTOBER 21, 2024

A 5-year-old generally healthy fully immunized boy presented to the ED with worsening left ear redness, swelling, and tenderness that his family noticed the day before presentation. His family had also recently noticed an abrasion over that ear.

Medical Schools 169

Medical Schools Immunity Immunization 169

pharmaphorum

SEPTEMBER 10, 2020

The spray is based on the SporeVax technology developed at Sporegen by Royal Holloway University Professor Simon Cutting and takes the form of heat killed spores of a bacterium – Bacillus subtilis – that stimulate a part of the innate immune system known as mucosal immunity.

Vaccines 133

Vaccines Adverse Reactions Immunity Immunization 133

Pharmacy Joe

OCTOBER 18, 2023

In this episode, I’ll discuss why hypokalemia can result from digoxin immune fab fragment administration. With the administration of antidote therapy with digoxin immune fab fragments, the function of the sodium-potassium ATPase pump is restored.

Immunity 52

Immunity Immunization Hospitals Inpatient 52

Pharmacy Joe

OCTOBER 18, 2023

In this episode, I’ll discuss why hypokalemia can result from digoxin immune fab fragment administration. With the administration of antidote therapy with digoxin immune fab fragments, the function of the sodium-potassium ATPase pump is restored.

Immunity 52

Immunity Immunization Hospitals Inpatient 52

Express Pharma

SEPTEMBER 26, 2023

Their research, conducted in collaboration with scientists from Dayanand Medical College and Hospital in Punjab and the CSIR-Institute for Himalayan Bioresource Technology in Himachal Pradesh, presents a novel, faster, and more effective approach to producing vaccines for challenging infectious diseases.

Vaccines 111

Vaccines Immunity Immunization Hospitals 111

European Pharmaceutical Review

DECEMBER 12, 2023

He discusses why NK cell therapy’s ability to generate ‘synthetic immunity’ in the body means this modality holds potential as an anti-cancer treatment. We specialise in the development of new cutting-edge immunotherapies , based on the use of therapeutic antibodies capable of activating the immune system to fight cancer.

Immunity 124

Immunity Immunization Chemotherapy Pharmaceutical Companies 124

Express Pharma

OCTOBER 5, 2023

Data from these trials were most recently presented at the 2023 American Academy of Dermatology (AAD) Annual Meeting in March and previously presented at the 31st European Academy of Dermatology and Venereology Congress. The post US FDA accepts Sun Pharma’s NDA for Deuruxolitinib appeared first on Express Pharma.

Immunity 104

Immunity Immunization 104

PharmaTech

APRIL 2, 2024

Experts believe it is likely cancer cells are more common in the body than previously thought, but typically caught early and removed in the body’s cancer-immune cycle. When the system is in good working order (and protecting us), dead cancer cells release neoantigens.

Immunity 52

Immunity Immunization 52

pharmaphorum

JULY 18, 2022

CanSinoBIO’s inhalant has finished phase three trials in China and is presently undergoing trials in several countries. It then elicits an immune response against that spike protein. When you have mucosal immunity, the immunoglobulins called IgAs start neutralising the virus at the point of entry. The inhalant version.

Vaccines 138

Vaccines Health and Personal Care Stores Immunity Immunization 138

Pharmaceutical Technology

SEPTEMBER 14, 2022

Before TIL infusion, the patient undergoes lymphodepletion, which reduces the proportion of myeloid immune suppressive cells and creates space for the incoming lymphocytes. The high level of neoantigens in melanoma makes this the ideal setting for TIL therapy, with tumours often containing multiple clones of tumour-reactive immune cells.

Immunity 98

Immunity Immunization 98

Pharmaceutical Business Review

MARCH 12, 2025

The research group at MD Anderson will carry out experiments to assess the preliminary efficacy and mechanistic data of the therapy, especially when combined with immune checkpoint inhibitors (ICIs) for treating HNSCC tumours. The company is set to retain the therapys title, interest, and complete rights.

Immunity 52

Immunity Immunization 52

Express Pharma

APRIL 17, 2023

Prometheus is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialisation of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases.

Immunity 98

Immunity Immunization Research Laboratories Labelling 98

European Pharmaceutical Review

DECEMBER 15, 2023

The companies previously presented data from KEYNOTE-942/mRNA-4157-P201, with a follow-up of approximately two years, at the American Association for Cancer Research (AACR) Annual Meeting, and the American Society of Clinical Oncology (ASCO) Annual Meeting. The most common adverse events were fatigue, injection site pain and chills.

Vaccines 115

Vaccines Research Laboratories Immunity Immunization 115

Pharmafile

APRIL 3, 2023

aVaxziPen, a biotech company focusing on the development of a novel needle-free vaccine delivery platform, has announced that it will present data at the World Vaccine Congress (WVC) in Washington, US. read more

Vaccines 72

Vaccines Immunity Immunization 72

Express Pharma

JULY 12, 2024

In the context of modern medicine, messenger RNA (mRNA) serves as the hacker, carrying genetic instructions to produce specific proteins within cells that can induce desired immune responses or sequester maladaptive cellular elements.

Immunity 103

Immunity Immunization Compounding Vaccines 103

Pharmaceutical Technology

MAY 26, 2023

was powered by the advent of immune-checkpoint inhibitors, added Chalk. Checkpoint modulators, cytokines and oncolytic viruses are also considered as part of the overall immune-oncology field. Apart from providing an overview of the current pipeline, the webinar also presented the findings from a GlobalData survey.

Immunity 105

Immunity Immunization Vaccines Compounding 105